STOCK TITAN

Freenome (FRNM) Financials

FRNM NASDAQ

Ticker history: PCSC became FRNM (Freenome, Inc.) on . Earlier news and filings retain their original names and dates. View PCSC history.

Trailing 12 months to September 30, 2026
Revenue Not reported for the trailing 12 months
Net Income -$73.2M YoY not available
EPS (Diluted) Not reported for the trailing 12 months
Operating Cash Flow $82.1M YoY not available
Market Cap $1.0B as of Nov 20, 2026
Price / Sales n/m no full year of revenue reported yet
Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to September 30, 2026
Price / Book 2.2x on $481.3M equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 20, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Key Financial Metrics

Export CSV

No financial data available for Freenome, Inc..

Financial data is sourced from SEC filings. This company may not have filed yet or may trade on a non-US exchange.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Castle Biosciences, Inc. CSTL FY2025 $344.2M -$24.2M -7.0% $1.0B 61/100
Opko Health Inc. OPK FY2025 $606.9M -$225.7M -37.2% $1.2B 41/100
GeneDx Holdings Corp. WGS FY2025 $427.5M -$21.0M -4.9% $1.4B 48/100
Personalis, Inc. PSNL FY2025 $69.6M -$81.3M N/A $1.5B 52/100
Fulgent Genetics, Inc. FLGT FY2025 $322.7M -$60.5M -18.8% $673.9M 45/100
Back to top